Board of Directors |
Legal Information |
Press Releases |
Richard Donald Bucholz attended Yale College, receiving a bachelor in science Cum Laude in molecular biochemistry and biophysics in 1973. He continued at Yale for his medical education and completed a general surgical internship and neurosurgical residency at Yale New Haven Medical Center. He was an Instructor at Yale in 1982-83 before accepting a position of assistant professor at Saint Louis University School of Medicine under Dr. Kenneth R. Smith, Jr. He was certified by the American Board of Neurological Surgery in 1985, and became a full professor in 1996. He is Professor and Vice Chairman of the Department of Neurosurgery and continues his entrepreneurial interest in medical technology. Dr. Bucholz holds a total of 22 patents and others are pending. He is a Fellow of the American College of Surgeons and is a member of numerous medical societies, and has been involved with the Radiosurgery Society for many years and currently serves as President.
Shalom Kalnicki is Professor and Chairman of the Department of Radiation Oncology at Montefiore Medical Center and Albert Einstein College of Medicine. A physician leader, researcher and teacher, Dr. Kalnicki leads an internationally recognized radiation oncology department since July 2004, when he rejoined the ranks of Montefiore-Einstein.
Throughout his career, Dr. Kalnicki has focused on researching and implementing new technologies in the radiation treatment of cancer. He pioneered the use of intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), target motion management with 4-D radiation planning, stereotactic body radiation therapy (SBRT) and functional tumor imaging with PET-CT fusion techniques. His research has implications for radiation treatment planning and techniques used for most clinical situations in radiation oncology, including brain, head and neck, thoracic, upper abdominal and pelvic malignancies. His research interests also include quality-of-life issues such as socio-economic disparities in radiation oncology and the impact of family caregiver support on patients’ compliance. In April 2016 Dr. Kalnicki was elected as President-Elect of the Board of Directors.
John Kresl completed advanced medical educational and research training in the field of oncology as a National Institute of Health (N.I.H.) supported combined MD/PhD Fellow in Graduate Medical Science training in Molecular and Immunological Tumor Cell Biology, culminating in a Doctor of Philosophy Degree from Northwestern University Graduate School, Evanston, Illinois. In addition to basic science training, Dr. Kresl completed his clinical medical training, receiving a Medical Doctorate Degree from Northwestern University Medical School in Chicago, Illinois. In addition to remaining active in Oncology research, Dr. Kresl is very involved in clinical practice in radiation oncology for all tumor sites. Dr. Kresl has been the principal investigator and co-investigator on dozens of clinical protocols and has published over 150 abstracts, manuscripts and book chapters related to radiation oncology, including editing the first two textbooks on Robotic Radiosurgery. He frequently is an invited lecturer on these topics around the world. Dr. Kresl is Board Certified by the American Board of Radiology in Radiation Oncology. He joined the Board of Directors of the Radiosurgery Society in 2007 and currently serves as Treasurer.
Hale Basak Özkök Çaglar is an Associate Professor of Radiation Oncology and head of the department at Medipol University Hospital, Istanbul, Turkey. From 1998 – 2006 she worked in the Gamma Knife Unit of the neurosurgery department at Marmara University, the first Gamma Knife site in Turkey. During her fellowship at Brigham and Women’s Hospital and Dana Farber Cancer Institute, Harvard University in Boston, she worked in thoracic and head and neck oncology and was introduced to and worked with Novalis. Upon her return to Turkey she focused on neuro-oncology, Gamma Knife, thoracic oncology and pediatric tumors. In 2010 while at Acibadem University and Acibadem Maslak Hospital, Istanbul Dr. Caglar was introduced to the CyberKnife and Trilogy Linac. In late 2012 she became the director of Medipol University Hospital Radiation Oncology Department and Gamma Knife Unit with neurosurgery.
Iris C. Gibbs, MD, FACR, Associate Professor of Radiation Oncology and Associate Dean of MD Admissions at Stanford Medicine. Dr. Gibbs’ clinical and research expertise are pediatric and adult brain tumors, and robotic radiosurgery. As former Co-Director of Stanford CyberKnife Radiosurgery program, Dr. Gibbs contributed to building world- renowned clinical programs in innovative radiation treatment of central nervous system tumors and robotic radiosurgery. Dr. Gibbs has served as committee chair for the Radiosurgery Society (formerly CyberKnife Society) and is a dedicated member of the International Stereotactic Radiosurgery Society (ISRS).
In 2014, Dr. Gibbs was appointed as Associate Dean for Medical School Admissions of Stanford Medicine. She is a 2015 Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Fellow and a fellow of the American College of Radiology. In addition to leadership service roles for Radiological Society of North America (RSNA), American Society of Radiation Oncology (ASTRO), and the American Board of Radiology (ABR), Dr. Gibbs is the current vice chair of the Section on Radiology for the National Medical Association. Dr. Gibbs became a board member in April 2016.